Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience

PURPOSE: Several targeted agents demonstrated efficacy in early clinical trials for gastrointestinal (GI) cancers, but in many cases, phase-III trials and/or approval by the European Medicines Agency (EMA) are lacking. The primary focus of this study was to assess the regulatory processes associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Welland, Sabrina, deCastro, Tiago, Bathon, Melanie, Wirth, Thomas Christian, Reineke-Plaaß, Tanja, Saborowski, Michael, Lehmann, Ulrich, Saborowski, Anna, Vogel, Arndt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293869/
https://www.ncbi.nlm.nih.gov/pubmed/34436668
http://dx.doi.org/10.1007/s00432-021-03774-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293869/
https://www.ncbi.nlm.nih.gov/pubmed/34436668
http://dx.doi.org/10.1007/s00432-021-03774-5

Ejemplares similares